Page 1 | Search Results | Blood | American Society of Hematology

1-10 of 10

Sort by

Sort Order Select

Journal Articles

Hyper- N -glycosylated SAMD14 and neurabin-I as driver autoantigens of primary central nervous system lymphoma

Blood (2018) 132 (26): 2744–2753.

https://doi.org/10.1182/blood-2018-03-836932

Published: 2018

Includes: Supplemental data

Journal Articles

Identification of Posttranvslationally Modified Neoantigens As Targets of B Cell Receptors of Burkitt Lymphoma

Lorenz Thurner, MD, Sylvia Hartmann, MD, Theresa Bock, Natalie Fadle, Maria Kemele, Evi Regitz, Moritz Bewarder, MD, Sigrun Smola, Thorsten Pfuhl, Jana Held, Rainer-Maria Bohle, Laurence de Leval, MD, Rabea Wagener, Reiner Siebert, PhD, Martin-Leo Hansmann, Stephan Stilgenbauer, MD PhD, Klaus Dieter Preuss, PhD, Michael Pfreundschuh, MD

Blood (2018) 132 (Supplement 1): 1588.

https://doi.org/10.1182/blood-2018-99-114209

Published: 2018

Journal Articles

BAR-Bodies: B-Cell Receptor Antigens As the Targeting Moiety of Antibodies in Substitution for the Variable Region of Heavy and Light Chains

Moritz Bewarder, MD, Lorenz Thurner, MD, Frank Neumann, PhD, Natalie Fadle, Evi Regitz, Maria Kemele, Helene Will, Lisa Goerens, Konstantinos Christofyllakis, MD, Dominic Kaddu-Mulindwa, MD, Stephan Stilgenbauer, Maximilian Kiefer, Klaus Dieter Preuss, PhD

Blood (2018) 132 (Supplement 1): 2940.

https://doi.org/10.1182/blood-2018-99-115348

Published: 2018

Journal Articles

Origin of (sporadic) Plasma Cell Myeloma: Lysolipids Are Not the Target of Clonal Immunoglobulins

Michael Pfreundschuh, MD, PhD, Natalie Fadle, Evi Regitz, Maria Kemele, Klaus-Dieter Preuss, PhD

Blood (2016) 128 (22): 2055.

https://doi.org/10.1182/blood.V128.22.2055.2055

Published: 2016

Journal Articles

LRPAP1 Is a Frequent B-Cell Receptor Antigen in Mantle Cell Lymphoma (MCL)

Lorenz Thurner, MD, Sylvia Hartmann, Klaus-Dieter Preuss, PhD, Natalie Fadle, Maria Kemele, Evi Regitz, Christiane Pott, MD PhD, Rainer-Maria Bohle, Martin-Leo Hansmann, Michael Pfreundschuh, MD

Blood (2015) 126 (23): 2685.

https://doi.org/10.1182/blood.V126.23.2685.2685

Published: 2015

Journal Articles

BARs ( B -cell receptor a ntigens for r everse targeting): A Novel and Ultimately Specific Treatment Concept for B-Cell Neoplasms

Michael Pfreundschuh, MD, Lorenz Thurner, MD, Stefan Barth, Prof.Dr., Diana Pickert, Natalie Fadle, Maria Kemele, Evi Regitz, Frank Neumann, PhD, Thomas Nachreiner, Dr., Klaus-Dieter Preuss, PhD

Blood (2015) 126 (23): 3995.

https://doi.org/10.1182/blood.V126.23.3995.3995

Published: 2015

Journal Articles

Identification of the Antigenic Targets of the Major CLL-Derived Stereotyped BCRs and First Demonstration of Sub-Subsets

Klaus-Dieter Preuss, Natalie Fadle, Evi Regitz, Maria Kemele, Manuela Wölfle, Stephan Stilgenbauer, MD, Michael Pfreundschuh, Prof MD

Blood (2014) 124 (21): 298.

https://doi.org/10.1182/blood.V124.21.298.298

Published: 2014

Journal Articles

Postranslationally Modified Proteins in the Central Nervous System (CNS) Are the Dominant Antigenic Target/Stimulus of the B-Cell Receptor (BCR) in Primary CNS Lymphomas (PCNSL) Providing Strong Evidence for the Role of Chronic Autoantigenic Stimulation As an Early Step in the Pathogenesis of Aggressive B-Cell Lymphomas

Lorenz Thurner, MD, Maria Kemele, Natalie Fadle, Evi Regitz, Patrick Roth, MD, Michael Weller, Prof., Monika Szczepanowski, Wolfram Klapper, Camelia-Maria Monoranu, MD, Andreas Rosenwald, MD, Rolf Buslei, MD, Rainer Maria Bohle, MD, Yoo-Jin Kim, MD, Klaus-Dieter Preuss, PhD, Michael Pfreundschuh

Blood (2014) 124 (21): 142.

https://doi.org/10.1182/blood.V124.21.142.142

Published: 2014

Journal Articles

Autoantigenic targets of B-cell receptors derived from chronic lymphocytic leukemias bind to and induce proliferation of leukemic cells

Carsten Zwick, Natalie Fadle, Evi Regitz, Maria Kemele, Stephan Stilgenbauer, Andreas Bühler, Michael Pfreundschuh, Klaus-Dieter Preuss

Blood (2013) 121 (23): 4708–4717.

https://doi.org/10.1182/blood-2012-08-447904

Published: 2013

Includes: Supplemental data

Journal Articles

Autoantigenic Targets of B-Cell Receptors (BCR) Derived From Chronic Lymphocytic Leukemias Bind to and Induce Proliferation of Leukemic Cells.

Klaus-Dieter Preuss, Gerhard Held, MD, Natalie Fadle, Evi Regitz, Maria Kemele, Stephan Stilgenbauer, MD, Andreas Buehler, MD, Michael Pfreundschuh, MD

Blood (2012) 120 (21): 2884.

https://doi.org/10.1182/blood.V120.21.2884.2884

Published: 2012

NARROW

Hyper- N -glycosylated SAMD14 and neurabin-I as driver autoantigens of primary central nervous system lymphoma

Identification of Posttranvslationally Modified Neoantigens As Targets of B Cell Receptors of Burkitt Lymphoma

BAR-Bodies: B-Cell Receptor Antigens As the Targeting Moiety of Antibodies in Substitution for the Variable Region of Heavy and Light Chains

Origin of (sporadic) Plasma Cell Myeloma: Lysolipids Are Not the Target of Clonal Immunoglobulins

LRPAP1 Is a Frequent B-Cell Receptor Antigen in Mantle Cell Lymphoma (MCL)

BARs ( B -cell receptor a ntigens for r everse targeting): A Novel and Ultimately Specific Treatment Concept for B-Cell Neoplasms

Identification of the Antigenic Targets of the Major CLL-Derived Stereotyped BCRs and First Demonstration of Sub-Subsets

Autoantigenic targets of B-cell receptors derived from chronic lymphocytic leukemias bind to and induce proliferation of leukemic cells

Autoantigenic Targets of B-Cell Receptors (BCR) Derived From Chronic Lymphocytic Leukemias Bind to and Induce Proliferation of Leukemic Cells.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only